Blue Jet Healthcare Limited (BOM:544009)

Market Cap	139.66B
Revenue (ttm)	12.22B
Net Income (ttm)	3.59B
Shares Out	n/a
EPS (ttm)	20.67
PE Ratio	38.95
Forward PE	34.58
Dividend	1.00 (0.13%)
Ex-Dividend Date	Sep 17, 2024

Volume	47,151
Average Volume	89,939
Open	792.00
Previous Close	778.70
Day's Range	781.60 - 812.15
52-Week Range	454.75 - 1,028.20
Beta	n/a
RSI	43.00
Earnings Date	Jul 29, 2025

About Splunk

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norw...

• Industry: Pharmaceutical Preparations
• Founded: 1968
• Employees: 447
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544009

Financial Performance

In 2024, Blue Jet Healthcare's revenue was 10.30 billion, an increase of 44.74% compared to the previous year's 7.12 billion. Earnings were 3.05 billion, an increase of 86.38%.